Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose Dual Therapy vs Bismuth Quadruple Therapy for H. pylori Eradication
NCT02483715Phase 4Completed
- Sponsor
- National Taiwan University Hospital
- Start
- Jul 2015
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rabeprazole, amoxicillin in Helicobacter pylori infection, sponsored by National Taiwan University Hospital. Started Jul 2015; status: completed.
02
Drugs
rabeprazoleamoxicillin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT02483715.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02483715.